This session provides a focused overview of substance use disorders during pregnancy, with particular emphasis on opioid use disorder and the physiologic changes that influence risk, relapse, and treatment. Aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas, the session explores evidence-based approaches to screening, assessment, treatment, and longitudinal care for pregnant and postpartum patients with substance use disorders.
What This Covers
• Physiologic changes during pregnancy and their impact on substance use, relapse risk, and treatment considerations
• Maternal and fetal risks associated with substance use during pregnancy
• Screening, assessment, and identification of substance use disorders in pregnant patients
• Management considerations for commonly encountered substances during pregnancy
• Evidence-based treatment approaches for opioid use disorder, including methadone and buprenorphine
• Initiation, adjustment, and ongoing management of medications for opioid use disorder during pregnancy and the postpartum period
• Care of the mother–infant dyad and strategies to support long-term engagement in treatment and recovery
How This Resource Is Used
This session is designed for on-demand learning, focused content review, and board preparation. It may be used to reinforce foundational addiction medicine concepts, supplement fellowship training, or support preparation for addiction medicine certification examinations. Learners can engage with specific topic areas independently or complete the full session as part of a structured study plan.